Berre MERCÜMEK

Ms. Berre MERCÜMEK

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YAYunus Emre emre Ayhan
Yunus Emre emre Ayhan
MAMüzeyyen Aksoy
Müzeyyen Aksoy
YAYahya Abdulrahman
Yahya Abdulrahman
ZEZeynep Safiye Şahin Eröksüz
Zeynep Safiye Şahin Eröksüz
DVDuygu Vezir
Duygu Vezir
MSMesut Sancar
Mesut Sancar
Background: Pulmonary embolism (PE) poses significant morbidity and mortality risks, necessitating tailored anticoagulant therapy. Limited studies investigate the drug-related problems (DRPs) in PE. This study aims to evaluate the impact of clinical pharmacist (CP) interventions on drug-related problems (DRPs) and clinical outcomes in outpatients with PE. By addressing DRPs in this specific population, the study seeks to assess the role of CP-led interventions in enhancing patient safety and optimizing treatment outcomes. Methods: A randomized controlled trial was conducted on PE patients at a pulmonology outpatient clinic over the period of 15 January 2022 to January 2023. In this trial, the intervention group (IG) benefited from CP recommendations targeting DRPs, while the control group (CG) was observed without any additional interventions. Follow-ups were conducted at 90 and 180 days post-discharge. The study focused on DRPs, CP interventions, and patient outcomes. Data were systematically recorded and analyzed, adhering to ethical standards and employing the PCNE v9.1 classification system. Results: The study followed 50 PE patients, with 26 in the IG and 24 in the CG. DRPs, mostly in drug and dose selection, affected 84% of participants (3.34 DRPs/patient). In the IG, the CP made 76 recommendations (91.5%) for 83 DRPs at the prescribing physician level. Majority of these recommendations (94.7%) were accepted. At the 90-day follow-up, bleeding occurred in 16.6% of the CG, with none in the IG (odds ratio [OR] = 2.3, 95% confidence interval [CI]: 1.654–3.198, p = 0.046). As indicated by Cramér’s V (0.307), the effect size demonstrated a moderate association between the intervention and the absence of bleeding events in the IG. At the 180-day follow-up, bleeding was 33.3% in the CG and 16.6% in the IG (p = 0.443). Conclusions: PE patients experience common and frequent DRPs, especially in anticoagulation therapy. CP recommendations are widely accepted but need to be better implemented. No bleeding events were observed in the IG where a CP was involved at 90 days, unlike the CG. Including a CP in the PE treatment team seems to influence outcomes positively.

7 August 2025 in BMC Primary Care
Verified
Journal Article
Open access
PDF file
MBMuhammed Yunus Bektay
Muhammed Yunus Bektay
YAYunus Emre emre Ayhan
Yunus Emre emre Ayhan
MÇMerve Çakmak
Merve Çakmak
BMBerre MERCÜMEK
Berre MERCÜMEK
Community pharmacies (CPs) are key healthcare providers, playing a significant role in optimizing drug therapy and preventing drug-related problems (DRPs). This study aims to assess the prevalence, characteristics, and related factors of DRPs in Turkish patients in the community pharmacy setting. A cross-sectional, prospective study was conducted between December 2023 and December 2024 in a community pharmacy. A total of 100 patients were included after excluding those with incomplete data. DRPs were evaluated using the PCNE V9.1 classification system, while Medication Adherence Report Scale (MARS) and Medication Regimen Complexity Index (MRCI) were used to assess adherence and regimen complexity. A total of 162 DRPs were identified, with an average of 1.6 DRPs per patient. DRPs were significantly associated with factors such as higher body mass index (p = 0.005), polypharmacy (p < 0.001), use of antidiabetic (p < 0.001) and antihypertensive medications (p = 0.005), and a higher number of comorbidities (p = 0.005). No significant relationship was observed between medication adherence and DRPs (p > 0.05). This study is among the first in Türkiye to evaluate DRPs in chronic disease management within a community pharmacy setting. The findings highlight the importance of clinical pharmacists in identifying and managing DRPs and suggest the need for integrated interventions in healthcare teams to improve patient outcomes and medication safety.

4 November 2025 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
BMBerre MERCÜMEK
Berre MERCÜMEK
MBMuhammed Yunus Bektay
Muhammed Yunus Bektay
SUSelcuk Uzuner
Selcuk Uzuner
FIFikret Vehbi Izzettin
Fikret Vehbi Izzettin
Medication reconciliation (MedRec) is essential during transitions of care (ToC) to prevent errors, yet standardized tools to classify medication discrepancies are inconsistently applied in pediatrics. To address this gap, our study aims to assess the feasibility of the Medication Discrepancy Taxonomy (MedTax) in identifying and classifying medication discrepancies in pediatric patients during ToC. A prospective cross-sectional study was conducted on pediatric patients hospitalized between August 2022 and February 2023. Patients < 18 years, hospitalized for ≥ 24 h, and prescribed ≥ 1 medication were included. Pharmacist conducted MedRec during admissions and transfers, classifying discrepancies as intentional or unintentional; only unintentional discrepancies were further categorised using MedTax. Statistical analyses were performed using Jamovi version 1.6. Among 105 patients (47.6% female; mean age 62.3 ± 61.3 months), the mean numbers of comorbidities and medications per patient were 0.75 ± 0.98 and 8.35 ± 5.56, respectively. In total, 518 medication discrepancies were identified, of which 47 (9.1%) were unintentional and 471 (90.9%) intentional. Among the unintentional discrepancies, 9 (19.2%) were partial and 38 (80.9%) were complete. All discrepancies were classified using MedTax, though 6.38% were difficult to categorize using the existing MedTax structure. This study shows the feasibility of using the MedTax taxonomy to identify and classify medication discrepancies in pediatric patients during ToC. While MedTax effectively categorized most discrepancies, challenges in classifying some highlight the need for refinement to address pediatric medication complexities. These findings emphasize the importance of developing tailored tools to improve medication reconciliation in pediatrics.

7 August 2026 in Trends in Pharmacy
Verified
Journal Article
Closed access
PDF file
SJSaad Ahmed Ali Jadoo
Saad Ahmed Ali Jadoo
MAMustafa Ali Mustafa Al-Samarrai
Mustafa Ali Mustafa Al-Samarrai
BMBerre MERCÜMEK
Berre MERCÜMEK
FIFikret Vehbi İzZettin
Fikret Vehbi İzZettin
Background: Prescription and medication errors account for a significant proportion of preventable adverse events affecting patients. This study aimed to assess physicians’ knowledge, attitudes, and prescribing practices related to medication safety and to identify factors associated with good prescribing practices. Methods: A cross-sectional study was designed to survey physicians working at tertiary and major specialty hospitals in Diyala Governorate, Iraq. Data were collected among 137 respondents between March and August 2025 using a structured questionnaire consisting of 32 items assessing sociodemographic characteristics, knowledge of safe prescribing, attitudes toward medication safety, and prescribing practices. Descriptive statistics, chi-square tests, and binary logistic regression analysis were performed using Statistical Package for the Social Sciences, version 26 (IBM SPSS Corp.; Armonk, NY, USA). Results: The mean age of participating physicians was 41.2 ± 8.6 years, and 59.9% were females. The mean knowledge score was 7.14 ± 1.86, indicating moderate to good knowledge of safe prescribing practices. Physicians demonstrated positive attitudes toward medication safety with a mean attitude score of 38.4 ± 5.1. However, the mean prescribing practice score was 34.16 ± 6.27, and only 38 physicians (27.7%) demonstrated good prescribing practices. Logistic regression analysis identified training on safe prescribing (OR = 2.84; 95% CI: 1.31-6.12; P = .008) and knowledge level (OR = 1.32; 95% CI: 1.05-1.66; P = .02) as independent predictors of good prescribing practice. Conclusion: Despite adequate knowledge and positive attitudes, physicians’ prescribing practices were suboptimal. Training programs and improved pharmacological knowledge are essential to enhance prescribing safety and reduce medication errors.